When the FTC and the U.S. Supreme Court start breathing down your neck it’s not a pleasant thing, and could become very expensive for certain companies.
Keep Reading →
June 18 - News
It’s not easy being a biotech company.
Keep Reading →
June 18 - News
About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease...
Keep Reading →
June 18 - News
Abbott Laboratories (NYSE:ABT) seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.
Keep Reading →
June 18 - News
Amgen, Inc. (NASDAQ:AMGN) is the world’s largest independent biotechnology company.
Keep Reading →
June 18 - News
The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.
Keep Reading →
June 17 - Stock Analysis
The Food and Drug Administration (FDA) made a groundbreaking policy change last year that is having a large impact on the biotech industry and creating a big opportunity for...
Keep Reading →
June 17 - Stock Analysis
As we're now just days away from the next Federal Reserve meeting, fear, concern, and, most importantly, uncertainty ran rampant this past week on Wall Street, causing the three...
Keep Reading →
June 17 - News
In the "Global Burden of Disease" report from the World Health Organization, which was compiled over a 20-year period from 1990 through 2010 using data from 500 researchers from...
Keep Reading →
June 17 - News
It was another fear-filled week, as investors were concerned that the Federal Reserve may soon begin taking its foot off the gas.
Keep Reading →
June 17 - News
When we go to the hospital, the last thing on our mind is that something could go wrong or that we could actually become sicker than when we first went in.
Keep Reading →
June 17 - News
The latest drug to bite the dust is LY2886721, a beta secretase, or BACE, inhibitor.
Keep Reading →
June 17 - News
The markets sure lost yesterday's momentum in a hurry.
Keep Reading →
June 14 - News
With the global economy beginning to stabilize, the stock market is looking more attractive than ever.
Keep Reading →
June 14 - News
Investing in biotech stocks is relatively risky amid the volatility of the market. There are many factors that can greatly affect share trends and price performance.
Keep Reading →
June 13 - News
Generic-drug makers are always on the hunt for the next branded drug to take down.
Keep Reading →
June 13 - News
Pfizer Inc. (NYSE:PFE) recently completed the spin-off of its animal health unit, Zoetis Inc (NYSE:ZTS).
Keep Reading →
June 13 - News
Celgene Corporation (NASDAQ:CELG) shares have soared more than 46% so far in 2013.
Keep Reading →
June 12 - News
The back-and-forth trend on Wall Street continued today as markets opened higher only to fall throughout the trading day.
Keep Reading →
June 12 - News
Billionaire Paul Tudor Jones (PTJ) has been all over the news after telling an audience of University of Virginia students and others that it's difficult for mothers to be...
Keep Reading →
June 12 - Hedge Funds
The Dow Jones Industrial Average is sinking today, but don't blame it on Hewlett-Packard Company (NYSE:HPQ) this time.
Keep Reading →
June 12 - News
The Dow Jones Industrial Average is following markets in Asia and Europe lower today. As of 1:20 p.m. EDT the Dow is down 58 points, or 0.39%, to 15,064.
Keep Reading →
June 12 - News
Nearly every big pharma player has been hit with patent expirations that have hit hard on sales lately, and Merck & Co., Inc. (NYSE:MRK) is no exception. Merck & Co., Inc.
Keep Reading →
June 12 - News
The biggest pharmaceutical companies in the United States are in an enviable position. They sell products that are literally a matter of life and death.
Keep Reading →
June 12 - News
Merck & Co., Inc. (NYSE:MRK) has been trying to generate more value for its shareholders via its share buyback program.
Keep Reading →
June 12 - News
After the announcement from the Bank of Japan that it will hold firm with its economic stimulus, the U.S. markets headed south.
Keep Reading →
June 12 - News
Pharmaceutical giant Merck & Co., Inc.
Keep Reading →
June 11 - News
Celgene Corporation (NASDAQ:CELG)’s Abraxane is primarily used to treat breast and lung cancer.
Keep Reading →
June 10 - News
Move over, Superman: There's a more unstoppable force that can leap even the highest expectations, and its name is the Dow Jones Industrial Average.
Keep Reading →
June 10 - News
Billionaire Stanley Druckenmiller founded his Duquesne Capital hedge fund in 1981. It now has some $10 billion in assets under management.
Keep Reading →
June 10 - Hedge Funds
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
Keep Reading →
June 10 - News
Lately, many investors have sought protection from a potential downturn by turning to low-volatility stocks, which they perceive as somehow being safer than higher-volatility ...
Keep Reading →
June 10 - News
Editor's Note: This article initially mentions Pfizer (NYSE:PFE)'s " consistent increasing dividends." In light of the fact that Pfizer cut their dividend in half during 2009, ...
Keep Reading →
June 10 - News
It was quite the week on Wall Street.
Keep Reading →
June 10 - News
It was another wild week on Wall Street, but at the end of the week the Dow Jones Industrial Average was up 0.88% and the S&P 500 had gained 0.78%.
Keep Reading →
June 10 - News
Pharmaceutical company Pfizer Inc. (NYSE:PFE) has been doing some interesting things lately.
Keep Reading →
June 7 - News
Having shed more than 100 points by early afternoon, the Dow Jones Industrial Average staged a comeback in its final hours of trading, as Wall Street looks to tomorrow's employment...
Keep Reading →
June 7 - News
With the Dow Jones Industrial Average (INDEXDJX:.DJI) closing today's trading session higher by 80 points, or 0.53%, the average investor seeing the headlines may just think it...
Keep Reading →
June 7 - News
Generic-drug makers have considerable tailwinds, making their outperformance in the past year unsurprising.
Keep Reading →
June 6 - News
Editor's Note: Related tickers: Apple Inc. (NASDAQ:AAPL), Pfizer Inc. (NYSE:PFE), Wells Fargo & Co (NYSE:WFC), American International Group, Inc.
Keep Reading →
June 6 - Hedge Funds
The market's slump continues for a third straight day, and the Dow Jones Industrial Average (INDEXDJX:.DJI) is back in the red again, with Chevron Corporation (NYSE:CVX) stock...
Keep Reading →
June 6 - News
The Dow Jones Industrial Average consists of 30 of the finest businesses in America. But within this elite group, you'll find some Dow stocks outperforming the others.
Keep Reading →
June 6 - News
When we think of big pharma companies, the company we think about constantly is Pfizer Inc.
Keep Reading →
June 6 - News
As I noted 12 weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
June 6 - News
In today's market place, there are many indicators for Pfizer Inc. (NYSE:PFE) readers to keep an eye on, but it's smart to take note of a stock's short interest.
Keep Reading →
June 6 - News
As the stock market has kept going up, many investors have thought about the possibility of another crash like 2008.
Keep Reading →
June 6 - News
In my portfolio, I hold a small position in a small biotech company by the name of Sangamo Biosciences, Inc. (NASDAQ:SGMO).
Keep Reading →
June 5 - News
Last week was a slow one in U.S.
Keep Reading →
June 4 - News